Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 2/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.47 |
| ▸ | LMNA | P02545 | 2/20 | 0.47 |
| ▸ | MEN1 | O00255 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.47 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.45 |
| ▸ | HPGD | P15428 | 2/20 | 0.45 |
| ▸ | EPHX2 | P34913 | 3/20 | 0.44 |
| ▸ | RAB9A | P51151 | 3/20 | 0.44 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | NPC1 | O15118 | 1/20 | 0.43 |
| ▸ | FAAH | O00519 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6704475 | 0.97 | LMNA (0.49) | GAAALDH1A1SMN1; SMN2LMNAMEN1 | |
| SCHEMBL6704655 | 0.87 | NPC1 (0.49) | ALDH1A1SMN1; SMN2HPGDEPHX2RAB9A | |
| SCHEMBL6704728 | 0.80 | EPHX1 (0.48) | GAAALDH1A1SMN1; SMN2LMNAMEN1 | |
| SCHEMBL6703340 | 0.76 | GAA (0.49) | GAAALDH1A1SMN1; SMN2LMNAMEN1 | |
| SCHEMBL6704166 | 0.72 | HPGDS (0.48) | ALDH1A1LMNAKMT2AHPGDHTT | |
| Biphenyl SCHEMBL5492703 | 0.71 | MEN1 (0.63) | GAAALDH1A1SMN1; SMN2LMNAMEN1 | |
| SCHEMBL6703391 | 0.69 | PTPRC (0.40) | ALDH1A1SMN1; SMN2LMNAMEN1KMT2A | |
| SCHEMBL2983895 | 0.66 | NPC1 (0.84) | GAAALDH1A1SMN1; SMN2LMNAMEN1 | |
| SCHEMBL22289346 | 0.66 | NPC1 (0.84) | GAAALDH1A1SMN1; SMN2LMNAMEN1 | |
| SCHEMBL22308180 | 0.66 | NPC1 (0.84) | GAAALDH1A1SMN1; SMN2LMNAMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040102488-A1 | Butenolide and pentenolide derivatives as kinase inhibitors | MORPHOCHEM AG (DE) | 2004-05-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040102488-A1 | Butenolide and pentenolide derivatives as kinase inhibitors | MAP3K20, MAP3K21, MAP3K1 | GAA 1655/4885ALDH1A1 2905/4885SMN1; SMN2 4578/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.